Back to Rankings

ANIP

ANIB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
Current thesis
The strongest post-print bull read is that ANI paired a revenue/EPS beat with higher 2026 guidance, 42.1% Cortrophin growth, six generic launches year-to-date, and a new buyback authorization, while the 10-Q also showed $311.2M of cash and cash equivalents and $58.4M of operating cash flow for Q1, limiting immediate balance-sheet stress [#8-K-2026-05-08] [#10-Q-2026-05-08].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +12.9.
What can break
Brands revenue fell 50.9% year over year due to normalization in demand for certain products, reducing diversification support if Rare Disease momentum cools [#8-K-2026-05-08].
Momentum
45
Value
67
Sentiment
70
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $92.00 · Bull $102.00 · Bear $72.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $110.63
Why
Momentum45 · Δ7d -6.5
Value67 · Δ7d +0.7
Sentiment70 · Δ7d +12.9
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
45
34% active weight
Current posture
7d trendFlat
Δ7d
-6.5
Δ21d
-0.7
Value
67
32% active weight
Current posture
7d trendFlat
Δ7d
+0.7
Δ21d
+0.7
Sentiment
70
33% active weight
Current posture
7d trendImproving
Δ7d
+12.9
Δ21d
+11.7
Why this grade

Composite grade B. Momentum 44.6 / Value 67.0 / Sentiment 69.7

Fundamentals (TTM)
As of 2026-06-01
Market Cap
$1.74B
Beta
0.50
Shares Out
22.47M
P/E (TTM)
48.2
P/S (TTM)
2.14
P/FCF (TTM)
11.46
Rev YoY
+53.6%
EPS YoY
+189.5%
Gross Margin
+61.1%
Op Margin
+8.7%
Net Debt
$473.22M
Current Ratio
2.58
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology